DNMT3A and angioimmunoblastic T-cell lymphoma: Yao et al. reported higher mutation frequencies in TET2, RHOA, and DNMT3A in AITL (72%, 61%, and 34%) and PTCL-TFH (73%, 45%, and 36%) than in our study [9].